Ole Joe Biden falsely claims the new Georgia law 3-30-21, Liar in Chief -- “What I’m worried about is how un-American this whole initiative is. It’s sick. It’s sick … deciding that you’re going to end voting at five o’clock .... and they can't have bottled water! ... " -- ole joe biden [Fact check by The Washington Post] The Masters Golf Tourny Is Business as Usual in Georgia
4-6-21, NYTimes -- Georgia's elections law are caught up in a ridiculous riptide. Major league baseball has canceled its ALL STAR GAME in Georgia ... but the Master's Golf Tournament will proceed as planned. 2015 Patriotic Laws Passed - False |
Jeremiah 6:14; John 3:20 History Obama was in White House: June 3, 2015, Bill Wilson, Daily Jot [excerpt] -- It is a very rare thing these days when the “president,” the House, and the Senate agree on something. They did so on revising and extending the Patriot Act with another misnamed “spy on all US citizens” bill called the USA Freedom Act. Americans have become accustomed to major laws that are named the exact opposite of what they do: Patriot Act, Affordable Care Act, No Child Left Behind Act, Clean Air Act and so on. When this “president” and this Congress agree on anything, it should raise your suspicion. | The USA Freedom Act is a shell game being played on all Americans. It is another opportunity to continue spying on every American citizen, shifting accountability to a secret court. [..snip] Matthew 24:6; Mark 13:7 This Act is just appeasement to make people think the government has corrected something. In reality, Congress and the White House have just back-doored their ability to further oppress our freedom. We need to continue to expose these deeds and demand accountability, otherwise our freedom of religion and of speech will be crushed in darkness. [And six years later, 2021 ... they have.] |
Evangelicals Blast Rev Franklin Graham For Supporting Covid Jab 3-26-21, ReligionNews -- Franklin Graham recently reported that: “I have been asked if Jesus were physically walking on earth now, would He be an advocate for vaccines. I would have to say — yes, I think Jesus Christ would advocate for people using vaccines and medicines to treat suffering and save lives.” | The blowback was fast, and it was furious:
| Graham’s post kicked up a lot of dust, drawing 20,000 comments and nearly 10,000 shares. It was the top-three highest-performing Facebook posts the day it was posted. Though his supporters ultimately rallied online, the vituperative anti-vaxxers initially overpowered them. [..] Graham said he will stop short of requiring all Samaritan’s Purse employees to get the vaccine. But he’s also clear that if his employees must travel, they may not be able to perform their jobs if they are not vaccinated, because some airlines won’t allow them to fly. |
God's School of Obedience
The Apostle John said: "That which we have seen and heard declare we unto you, that ye also may have fellowship with us: and truly our fellowship is with the Father and with His Son Jesus Christ. And these things write we unto you, that your joy may be full. This then is the message which we have heard of Him, and declare unto you, that God is Light, and in Him is no darkness at all. If we say that we have fellowship with Him and walk in darkness, we lie, and do not the truth:"
1 John 1:3-6, 8-10; John 8:12-30, 14:15 12-17-20, Pastor Charles Stanley -- Starting at age five, our children are enrolled in school and given lessons to learn each year. We are students too. At salvation, we became participants in the Lord's school of obedience. There, we are discovering the necessity of trusting Him and waiting for His direction. We are taught the importance of commitment and learn to search His Word for guidance. God also wants us to learn these lessons: • Listen attentively to the Spirit's promptings. Our God does not speak in an audible voice, but He makes Himself heard quite clearly through the Holy Spirit. Jesus said the Spirit is our Helper who will bring to mind Scripture passages we have studied (John 14:26) and show us how they apply. Matthew 5:21, 40-26, 6:24, 22:13-39; Mark 7:21-23; Luke 16:15, 17:3, 18:9-14 | • Obey the next step. Abraham was called to leave his home and journey to an unknown destination (Gen. 12:1). He obeyed even though the way was unclear to his human mind. We, too, must step out in faith even when we do not know all the details of the itinerary. • Expect conflict. We can't live obedient lives without having trouble with the world (John 16:33). Our friends or family may drift away when they realize certain interests of ours have changed. Some may hurl criticism our way or call us unkind names, while others may reject us completely. Practicing a lifestyle of obedience doesn't mean we'll never make mistakes. But it does require diligence if we are to succeed. Obeying the Father was Jesus' priority and purpose in life, and we should make it ours as well. Which of these lessons do you want to tackle first? Source |
Last update: March 18, 2021
To help you sort through the news on the COVID-19 vaccine’s progress, MedShadow has created the MedShadow Vaccine Tracker, the only tracker focused on the side effects and adverse events associated with proposed COVID-19 vaccinations.
Rather than injecting patients with a weakened virus or proteins from the pathogen that our immune systems can recognize, which is what’s typically done when we get a flu vaccine, the new vaccines from Moderna and Pfizer — the two that made it to the market first in the U.S. — contain mRNA (messenger RNA), which is a genetic template that instructs our cells to build the viral proteins that our immune systems can then recognize.
Its main perk is that allowing our bodies to produce the proteins (rather than growing them in a lab like traditional vaccines) slashes production time. For nearly 20 years, researchers have been interested in using mRNA in vaccines; and some were even tested in early clinical trials for rabies, influenza and Zika. However, the vaccines for COVID-19 will be the first mRNA vaccines ever authorized by the FDA.
Some risks and side effects do occur:
Moderna started Phase III clinical trials for its vaccine candidate in July. In earlier trials, nearly half of patients experienced common adverse effects like injection site pain, rash, headaches, muscle soreness, nausea and fevers after the second injection. These effects generally subsided within two days. CNBC spoke to a few individuals, some participating in Moderna’s trial and some in Pfizer’s trial who said much the same thing: the side effects were intense and included a high fever, body aches, bad headaches and exhaustion, but were worth it for protection from Covid-19.
The CDC reports that 11% of patients experienced swollen lymph nodes after the first shot. That raised to 16% after the second shot. A few patients with facial fillers experienced swelling after receiving the vaccine. They were treated with antihistamines and steroids.
January 18: In California, officials halted the use of one particular batch of Moderna vaccines (lot 41L20A) after a cluster of patients at one particular site experienced allergic reactions that required medical attention.
February 1: patients who received the vaccine after having been previously infected with COVID-19 showed greater immune response to the first shot and more intense side effects that are associated with strong immune responses like fever and muscle aches. The study included patients who received either the Moderna or Pfizer vaccine. Some scientists believe these patients may only need a single shot to provide sufficient immunity, but more research is needed.
February 12: Out of the first 7.5 million doses administered from Dec 14- Jan 18, cases of anaphylaxis were reported to VAERS after the Moderna vaccine. No patients have died from anaphylaxis. Patients are now being monitored for 15-30 minutes after receiving the vaccine to watch for signs of anaphylaxis. The CDC suggests that anyone who has an immediate allergic reaction to a single dose of an mRNA vaccine (Moderna or Pfizer) should not get the second dose. If your reaction was not immediate, you may be referred to an allergy specialist. The vaccines do not contain polysorbate, but do have a related ingredient, polyethylene glycol (PEG). If you have an allergy to either of these chemicals, you should not get the vaccines.
Many patients are reporting injection site reactions that show up shortly after the injection or up to a week later. These reactions — which are characterized by swelling, redness, itching, rashes, heat and pain — are expected to last a day to a week. Physicians emphasize that while these effects can be scary, they are not dangerous and should not prevent someone from getting the second shot. So far, doctors do not report seeing these reactions after the second shot, however so few have been given so far that scientists are not sure how common it will be on round two.
_________
March 3: Allergy researchers at Mass General Hospital created a registry for healthcare professionals to report immediate and delayed reactions to COVID-19 vaccinations. On March 3, the researchers published a letter in the New England Journal of Medicine describing a series of 12 delayed injection site reactions including swelling and rashes. The researchers wrote that one patient received antibiotics although they were not necessary. Several others were treated with steroids or anti inflammatories. The letter included some photos and said that the reactions cleared up within a median of six days. Patients were encouraged to receive their second dose. Half of them did not experience the reaction the second time. A quarter did, but to a lesser degree. March 8: Researchers from Mass General Brigham published a Research Letter in JAMA analyzing allergic reactions in employees who received their shots there. Out of 52,805 participants, 2.1% experienced some kind of allergic reaction, including hives, itching, rash, swelling or respiratory symptoms within the first three days after vaccination. Allergies were slightly more common with the Moderna vaccine than the Pfizer vaccine (2.2% compared to 1.95%). Sixteen experienced anaphylaxis. Moderna has announced that it will begin testing its vaccine in children and adolescents, who they believe may have stronger immune responses, leading to more intense side effects. Pfizer began Phase III clinical trial for its vaccine candidate in July. In earlier trials, some patients experienced common adverse effects like injection site pain, rash, headaches, muscle soreness, nausea and fevers. These effects generally subsided within two days. CNBC spoke to a few individuals, some participating in Pfizer’s trial and others in Moderna’s trial who said much the same thing: the side effects were intense and included a high fever body aches, bad headaches and exhaustion in addition to the more common side effects, but were worth it for protection from Covid-19. Some patients described the side effects as being similar to a bad hangover. A nurse who participated in the clinical trial reported feeling minimal effects after the first dose, but a fever that reached more than 104 degrees Fahrenheit after the second injection, along with chills, headache, and intense injection site pain. According to researchers, her experience of having all symptoms together was rare, though many patients had one or two of these side effects. “Clinicians will need to be prepared to discuss with patients why they should trust the vaccine and that its adverse effects could look a lot like COVID-19,” the nurse wrote on Dec 7. The FDA report published in December said the most common reactions were injection site reactions (84.1%), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), joint pain (23.6%), fever (14.2%). Swollen lymph nodes occurred in 0.3% of patients. The FDA reported that four patients who received the vaccine experienced Bell’s Palsy. January 12: A doctor in Florida died 16 days after receiving the vaccine from a rare blood disorder, acute immune thrombocytopenia. Both Pfizer and the CDC are investigating, though the company has released a statement that so far, they haven’t seen any signs in the clinical trials or data collected from early vaccinations that the death could be related to the vaccine. The blood disorder immune thrombocytopenia, has also been seen as a rare complication of COVID-19 itself, in both symptomatic and asymptomatic patients. January 19: Twenty-three elderly patients in Norway died after receiving Pfizer’s vaccine. Officials are investigating whether or not the deaths are vaccine-related. Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, suggests that while the deaths may be coincidental given the fragile population, it’s possible that side effects of the vaccines, like fevers, may have strained the frail patients’ bodies and contributed to their deaths. Norway has vaccinated about 45,000 people so far, most of whom live in nursing homes. February 1: A study posted on Feb 1 showed that patients who received the vaccine after having been previously infected with COVID-19 showed greater immune response to the first shot and more intense side effects that are associated with strong immune responses like fever and muscle aches. The study included patients who received either the Moderna or Pfizer vaccine. Some scientists believe these patients may only need a single shot to provide sufficient immunity, but more research is needed. February 12: Out of the first 9.9 million doses administered from Dec 14- Jan 18, 47 cases of anaphylaxis were reported to VAERS after the Pfizer vaccine. Patients are now being monitored for 15-30 minutes after receiving the vaccine to watch for signs of anaphylaxis. The CDC suggests that anyone who has an immediate allergic reaction to a single dose of an mRNA vaccine (Moderna or Pfizer) should not get the second dose. If your reaction was not immediate, you may be referred to an allergy specialist. The vaccines do not contain polysorbate, but do have a related ingredient, polyethylene glycol (PEG). If you have an allergy to either of these chemicals, you should not get the vaccines. | March 8: Researchers from Mass General Brigham published a Research Letter in JAMA analyzing allergic reactions in employees who received their shots there. Out of 52,805 participants, 2.1% experienced some kind of allergic reaction, including hives, itching, rash, swelling or respiratory symptoms within the first three days after vaccination. Allergies were slightly more common with the Moderna vaccine than the Pfizer vaccine (2.2% compared to 1.95%). Sixteen experienced anaphylaxis. CanSinBio, China granted the CanSinBio vaccine emergency approval prior to beginning a Phase III trial in August. In the Phase II trial, nearly three-quarters of patients reported at least one common mild adverse events including injection site pain, rash, headaches, muscle soreness, and fevers. Five people also reported vomiting.Gamaleya Research Institute, Russia launched Phase III trials in August. But before they got started, President Putin announced that the vaccine was approved early, however, the Phase III trials are expected to continue. In the earlier trials, almost all of the patients experienced low-grade fevers. A small number of patients reported heart palpitations. Otherwise, reported side effects were similar to other vaccines and included injection site pain, rash, headaches, and muscle soreness. On Feb 1, the group reported efficacy data along with some data on side effects in The Lancet. The most common adverse events were flu-like illness (15.2% of those vaccinated) and local reactions (5.4% of those vaccinated). The report also states that there were six grade 3 adverse events which were not associated with the vaccination: acute sinusitis, an exacerbation of urolithiasis along with renal colic and deep vein thrombosis (both associated with pre-existing comorbidities) and extremity abscess (due to physical injury and subsequent infection of the wound surface of the soft tissues of the finger). Johnson & Johnson started a Phase III trial for its vaccine candidate in September 2020, but paused it on October 12 due to an unexplained illness and remains on hold. The company announced it would restart the trial on October 26. Pauses are common during clinical trials to evaluate specific adverse events, but the company has not shared details about the illness experienced by one of the trial volunteers. In earlier trials, about 70% of patients experienced at least one mild adverse effect similar to those seen with other vaccines, including injection site pain, rash, headaches, muscle soreness, and fevers. On Feb 24, Johnson & Johnson shared data from its Phase III trials. The data suggested that while the vaccine is slightly less protective overall (but more protective against the 501Y.V2 variant that emerged from South Africa,) than the Moderna and Pfizer vaccines, it produced fewer side effects. The report says the most common reactions were injection site reactions (50.2%), fatigue (38.2%), headache (38.9%), muscle pain (33.2%), nausea (14.2%) and fever (9.0%). Reactions were more common in patients under 60 than over 60. Injection site pain lasted a median of 2 days, but up to 7 days in 2.3% of patients. Astrazeneca: On September 6, the company paused the trial to investigate a patient who developed transverse myelitis – dangerous inflammation of the spinal cord. Researchers determined that the incident was unrelated to the vaccine and quickly restarted the trial in most countries, however it remained paused in the US until October 26. On October 21, scientists reported a patient in the trial had died, however, according to a local newspaper, the patient was in the control arm of the trial, meaning they’d received a placebo instead of the vaccine, so the trial is ongoing. In earlier trials, many patients reported mild adverse effects similar to those associated with the other vaccines including injection site pain, rash, headaches, muscle soreness, and fevers. The team gave some of these patients preventative acetaminophen to reduce pain and fever. Nearly half of patients also experienced temporary neutropenia – a reduction in white blood cells that can make a person more susceptible to infections. The vaccine has been approved for use in the U.K., Argentina, India, E.U. and Mexico. March 11: Denmark has paused the use of the AstraZeneca vaccine while it investigates whether it is responsible for blood clots — one fatal — in some patients. “It is important for us that the citizens are confident in the offer we give them and trust that we can vouch for the quality of the vaccines we have in our program. Therefore, we react promptly until we have investigated whether there is a connection between the vaccine and the possible side effects ,” officials wrote in a press release. | March 15: Several other countries (Iceland, Norway, Denmark, Ireland, the Netherlands, Italy, France and Germany) have also paused use of the vaccine while unusual clotting events are investigated. Meanwhile, Thailand, which paused its use on Friday, March 12 restarted it on Sunday, March 14. On Sunday, AstraZeneca released a statement that its own review revealed “no increased risk” of clotting issues with the vaccine and that “So far across the EU and UK, there have been 15 events of DVT [deep vein thrombosis] and 22 events of pulmonary embolism reported March 18: The European Medicines Agency (EMA) issued a statement that the benefits of the AstraZeneca vaccine outweigh the risks. The vaccine is not associated with an overall risk of blood clots, though there may be a very small increased risk of certain types of clots. The statement reads, “These are rare cases – around 20 million people in the UK and EEA had received the vaccine as of March 16 and EMA had reviewed only 7 cases of blood clots in multiple blood vessels (disseminated intravascular coagulation, DIC) and 18 cases of CVST [clots in the vessels that drain blood from the brain.] A causal link with the vaccine is not proven, but is possible and deserves further analysis.” These cases were more common in women under the age of 55. Germany, France, Italy, Latvia, Bulgaria and Slovenia have all stated that they’d restart or continue to offer the AstraZeneca vaccine in light of the news. Novavax, England began Phase III clinical trials with its vaccine candidate in the United Kingdom in September and is had planned to start a trial in the United States in October. The trial was delayed due to manufacturing problems. The U.S. trial started on December 28. During Phase I/II trials, patients reported adverse events similar to those of other vaccine candidates, including injection site pain, rash, headaches, muscle pain, fever, nausea and vomiting. In July, Sinopharm, China launched Phase III trials of its two vaccine candidates in the United Arab Emirates, Peru, Morocco, and Argentina, which are now approved for limited use in healthcare workers in China and the UAE. In earlier trials of one of the vaccines, made in collaboration with Wuhan Institute of Biological Products, about 15% of the patients reported adverse events similar to those of other vaccine candidates, including injection site pain, rash, headaches, muscle pain, fever, nausea and vomiting. There is little data available about the second vaccine, made in collaboration with the Beijing Institute of Biological Products. Sinovac, China opened Phase III trials of its vaccine candidate, CoronaVac, in July. It is already being used with emergency approval for high risk individuals in China. The earlier trials showed that about a third of patients experienced adverse effects similar to those in other vaccine candidates like injection site pain, fever, and fatigue, but the study included few details about more specific symptoms like nausea, headaches, and vomiting. On November 10, the trial was halted in Brazil due to a participant’s death. However, researchers say the death was not vaccine-related and the trial should continue. It has not been halted in other countries. The Murdoch Children’s Research Institute, England is running a Phase III trial repurposing Bacillus Calmette-Guerin — a vaccine developed nearly a century ago to prevent tuberculosis infections — to prevent Covid-19. Since the vaccine has been around such a long time, there are many reports on its potential adverse effects and the vaccine itself has been altered to minimize many of them. Injection site reactions are common, and lymphadenitis, swelling of the lymph nodes, is common. Bharat Biotech announced it would begin Phase III trials in India on October 23. In early trials demonstrated side effect profiles similar to those of the other vaccines, including pain at the injection site, fatigue, headache, and fever. The country announced emergency approval, though no Phase III data was included in the announcement. https://medshadow.org/covid19-vaccine-side-effects/ |
41 percent Republicans and 11 percent Democrats refuse Covid Jab
www.bostonglobe.com
3-16-21, Poll finds that 41 percent of Republicans and 34 percent of independents leery of COVID-19 vaccine, but only 11 percent of Democrats refuse shots.
Risen with Christ
“If ye then be risen with Christ, seek those things which are above, where Christ sitteth on the right hand of God.”
Mark 16:19; Colossians 3:1 4-4-21, The wise believer revels in the fact of Christ’s resurrection. Some things in Scripture may be easier to identify with and apply, including Christ’s substitutionary death, but it is the resurrection that gives us power to live victoriously. “Like as Christ was raised up from the dead by the glory of the Father, even so we also should walk in newness of life” (Romans 6:4). We have been “crucified with Him, that the body of sin might be destroyed” (Romans 6:6). Nevertheless, we are risen with Him, as our text and elsewhere clearly teaches (Romans 6; Ephesians 2:1-10; etc.). This resurrection is an inward one, of course, but our bodily resurrection is also guaranteed by Christ’s bodily resurrection, should we physically die. “Knowing that he which raised up the Lord Jesus shall raise up us also by Jesus” (2 Corinthians 4:14). | Power to serve Him effectively comes through His resurrection, for we have access to the “exceeding greatness of His power to us-ward who believe, according to the working of His mighty power, Which He wrought in Christ, when He raised Him from the dead” (Ephesians 1:19-20). We have authority over all human and demonic institutions through Him who even now operates as head of the living church of His born again followers [John 3:3, 7]. Perhaps the most precious of all benefits of the resurrection is that “we have a great high priest, that is passed into the heavens” who is sympathetic to “the feeling of our infirmities; but was in all points tempted like as we are, yet without sin. Let us therefore come boldly unto the throne of grace, that we may obtain mercy, and find grace to help in time of need” (Hebrews 4:14-16). -- John D. Morris, PhD, Source |
Matthew 28:2-6
Non stop beautiful songs of worship
RESURRECTION DAY CELEBRATION! here
Mark 16:12-13, Luke 24:13-24
"And, behold, two of them went that same day to a village called Emmaus, which was from Jerusalem about threescore furlongs. And they talked together of all these things which had happened. And it came to pass, that, while they communed together and reasoned, Jesus Himself drew near, and went with them. But their eyes were holden that they should not know Him. And he said unto them, "What manner of communications are these that ye have one to another, as ye walk, and are sad?" And the one of them, whose name was Cleopas, answering said unto Him:
"Art thou only a stranger in Jerusalem and hast not known the things which are come to pass there in these days? "
And Jesus said unto them: "What things?"
And they said unto Him: "Concerning Jesus of Nazareth, which was a prophet mighty in deed and word before God and all the people: And how the chief priests and our rulers delivered Him to be condemned to death and crucified Him! But we trusted that it had been He which should have redeemed Israel: and beside all this, to day is the third day since these things were done. Yea, and certain women also of our company made us astonished, which were early at the sepulchre [grave]; and when they found not His body, they came, saying, that they had also seen a vision of angels, which said that He was alive. And certain of them which were with us went to the sepulchre, and found it even so as the women had said: but Him they saw not." He was risen as He said!
Psalm 33:12 ♥️🙏
Index
All
America Babylon
Angels
Animals
Apostles Martyrdom
CHRISTMAS
Comics
Easter
English Bible
Headlines
Health
Holiday
Hymns
Islam Terror
Israel
Lord's Supper
Myths
New Jerusalem
Persecution
QUOTES
SCIENCE
Scripture
Sports
US Politics
World
Jeremiah 6:11
GOD'S STRONG DELUSION
2 Thessalonians 2:10-12
__________
Matthew 15:13; Mark 13:20; Luke 20:35
John 6:37, 39, 44, 65
Hebrews 9:15
Revelation 17:14
https://www.youtube.com/watch?app=desktop&v=pdJ0zMv4N4o
Jeremiah 4
Author
Annette Greco-Meisner
Archives
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
Disclaimer: No violation of Copyright Law intended for any images or work presented - with no financial gain.
U.S. Title 17 Code § 107
Section 106A-117 of the U.S. Copyright Law. "Fair Use Notice"
Images and videos on this site may contain copyrighted material. That are made available for educational purposes only.